Zavegepant for acute migraine with CGRP preventives
Treatments studied
Part of Brain & nervous system clinical trials.
This study tests how well a new acute migraine medicine, zavegepant, works and is tolerated in people who are already taking a CGRP-targeting preventive medication. It may help you find an effective treatment when you get a migraine attack.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with migraine (with or without aura) by a doctor.
- You are at least 18 years old.
- You have between 2 and 8 migraine attacks per month.
- You have been on a stable dose of a CGRP-targeting preventive medication (like atogepant, eptinezumab, erenumab, fremanezumab, galcanezumab, or rimegepant) for at least 2 months or two doses.
- You have no other primary headache disorders (mild tension headaches are fine).
- You have not had a serious allergic reaction to zavegepant or its ingredients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new class of migraine medicines, called gepants, can relieve migraine pain quickly when given in the emergency department. If you're having a migraine and haven't taken pain medication recently, you might be able to join.
This trial studies how well a “gepant” medicine works for different types of migraine and how tolerable it is. It may help if you have frequent migraines and you can keep a headache diary as the study asks.
This study tests a medicine called rimegepant to see if it helps prevent migraines. If you have migraine at least 4 days per month, this might be for you.
This study tests a nasal spray called zavegepant to see how well it treats migraine attacks quickly. It may help people who have frequent migraines and need a fast-acting treatment.
This study tests whether rimegepant, a migraine medication, can help prevent migraines in women. It looks at how well it works in real-life settings for women who have frequent migraines.
This trial tests whether a medication called rimegepant can prevent migraines when you take it before a known trigger (like exercise or stress). It is for people who get migraines often and can predict when one might happen.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.